BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 10 analysts with an average price target of $49.39. This is a potential upside of $24.26 (96.54%) from yesterday's end of day stock price of $25.13.

Beam Therapeutics 's activity chart (see below) currently has 104 price targets and 80 ratings on display. The stock rating distribution of BEAM is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.3% with an average time for these price targets to be met of 64.87 days.

Highest price target for BEAM is $70, Lowest price target is $20, average price target is $38.75.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 05-Aug-2025. First documented stock forecast 01-Mar-2020.

Currently out of the existing stock ratings of BEAM, 7 are a HOLD (33.33%), 14 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$21

$-4.75 (-18.45%)

$25

2 months 2 days ago
(05-Aug-2025)

11/11 (100%)

$2.7 (14.75%)

145

Buy

$55

$29.25 (113.59%)

$78

5 months 1 days ago
(06-May-2025)

0/4 (0%)

$38.77 (238.88%)

Buy

$70

$44.25 (171.84%)

$105

5 months 1 days ago
(06-May-2025)

0/3 (0%)

$53.77 (331.30%)

$40

$14.25 (55.34%)

$57

5 months 15 days ago
(22-Apr-2025)

2/5 (40%)

$20.13 (101.31%)

4

Buy

$80

6 months 1 days ago
(06-Apr-2025)

0/7 (0%)

$54.31 (211.41%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 64.87 days on average for the stock forecasts to be realized with a an average price target met ratio 32.3

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Mani Foroohar with highest potential upside - $51.25

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Luca Issi with lowest potential downside - -$5.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?